Incidence and prevalence rates of coronary artery disease in women with and without rheumatoid arthritis in Kentucky Women's Health Registry.

IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Future cardiology Pub Date : 2023-10-01 Epub Date: 2023-11-01 DOI:10.2217/fca-2022-0075

Hassan Mousa, David Mannino

引用次数: 0

Abstract

Aim: To investigate the incidence and prevalence rates of coronary artery disease (CAD) in women with and without rheumatoid arthritis (RA). Methods: Data was collected from the Kentucky Women's Health Registry (2007, 2008, 2009 and 2010) with 3982, 6730, 6898 and 7944, respectively. Results: Women with RA and reported CAD were over 45 years. 10% of women with RA reported CAD, while 4% of women without RA reported CAD. The incidence of CAD in women with RA were 10, 5.2 and 3.4% while the incidence of CAD in women without RA were 2.2, 2.2 and 1.4% in 2007-2010, 2008-2010 and 2009-2010, respectively. Conclusion: The incidence and prevalence of CAD was greater in women with RA compared with women without RA.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

肯塔基州妇女健康登记处患有和不患有类风湿性关节炎的妇女冠状动脉疾病的发病率和患病率。

目的：了解女性类风湿性关节炎（RA）患者和非类风湿性关节病患者冠状动脉疾病（CAD）的发生率和患病率。方法：数据来自肯塔基州妇女健康登记处（2007年、2008年、2009年和2010年），分别为3982、6730、6898和7944。结果：患有RA并报告CAD的女性年龄超过45岁。10%患有RA的女性报告CAD，而4%没有RA的女性则报告CAD。2007-2010年、2008-2010年和2009-2010年，患有RA的女性CAD发病率分别为10%、5.2%和3.4%，而无RA的女性的CAD发病率则分别为2.2%、2.2%和1.4%。结论：RA患者CAD的发生率和患病率高于非RA患者。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Future cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

2.80

自引率

5.90%

发文量

期刊介绍： Research advances have contributed to improved outcomes across all specialties, but the rate of advancement in cardiology has been exceptional. Concurrently, the population of patients with cardiac conditions continues to grow and greater public awareness has increased patients" expectations of new drugs and devices. Future Cardiology (ISSN 1479-6678) reflects this new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy. Coverage will also reflect the major technological advances in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modeling and information management issues.